Efficacy of Individualized Aerobic Exercise Training in Patients With Inflammatory Bowel Disease
Not applicable · Testing 12-week individualized aerobic exercise training and 12-week control intervention… · 1 site · Ningbo Medical Center Lihuili Hospital
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
This study is testing 12-week individualized aerobic exercise training (a behavioral program) and 12-week control intervention followed by 12-week aerobic exercise training (a behavioral program) as supportive care (to help with symptoms or quality of life). Condition(s) listed: Inflammatory Bowel Disease (IBD).
Participants are assigned to groups by chance (randomized).
It is single-blind: participants do not know which group they are in.
This study does not use drug-development phases (it may test a device, diet, procedure, app, or care approach).
Who can join
- Ages 18 to 65
- Any sex
Some of the main requirements, copied from the record:
- Diagnosed with CD or UC for more than 3 months.
- Disease activity in remission or mildly active (CD: CDAI < 220; UC: pMS < 5).
- Baseline physical activity intensity is low, measured by the IPAQ Chinese version short form, and without a habit of "regular exercise".
Plus 1 more requirement(s). There are also 4 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 28 participants are expected to take part.
- Start date: 2025-05-01.
- Main results expected around 2027-05-01 (estimate from the record).
- 1 study site listed (1 marked recruiting) in China.
Main thing being measured
- Change in peak oxygen uptake (pVO2) (in ml/kg/min) (At baseline and the end of intervention at week 12)
In the researchers’ words
The goal of this clinical trial is to learn if a 12-week individualized aerobic training program helps manage inactive or mildly active inflammatory bowel disease (IBD) including Crohn's disease (CD) and ulcerative colitis (UC) in adult patients aged 18-65 years. It will also assess participant compliance and the safety of the training program.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Not applicable |
| Study type | Interventional |
| Conditions | Inflammatory Bowel Disease (IBD) |
| Lead sponsor | Ningbo Medical Center Lihuili Hospital |
| Enrollment | 28 (estimated) |
| Start date | 2025-05-01 |
| Primary completion (est.) | 2027-05-01 |
| First posted | 2025-02-03 |
| Last updated | 2025-12-16 |
| Official title | Telemedicine-based Individualized Aerobic Exercise Training in Adults With Inactive or Mildly Active Inflammatory Bowel Disease: A Semi-crossover Randomized Controlled Trial |
| ClinicalTrials.gov ID | NCT06804733 |
Interventions
- 12-week individualized aerobic exercise training (Behavioral)
After enrollment, subjects directly participate in a 12-week aerobic exercise training program. The training plan provides individualized progressive aerobic training based on their baseline physical activity level measured by International Physical Activity Questionnaire (IPAQ), with the exercise intensity being increased every four weeks. - 12-week control intervention followed by 12-week aerobic exercise training (Behavioral)
After enrollment, subjects first undergo a 12-week control intervention (i.e., routine treatment) and then participate in a 12-week aerobic exercise training program. The training plan provides individualized progressive aerobic training based on their baseline physical activity level IPAQ, with the exercise intensity being increased every four weeks.
Full eligibility criteria (from the record)
Inclusion Criteria: * Diagnosed with CD or UC for more than 3 months. * Disease activity in remission or mildly active (CD: CDAI < 220; UC: pMS < 5). * Baseline physical activity intensity is low, measured by the IPAQ Chinese version short form, and without a habit of "regular exercise". * Agree to participate in the study and accept a 12-week individualized aerobic exercise training program. Exclusion Criteria: * Pregnant or breastfeeding, or planning to become pregnant within the next 3 months. * Presence of physical movement disorders or other chronic diseases that limit physical activity. * Having an ileostomy. * History of anal or intestinal surgery within the past 3 months.
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| the Affiliated Lihuili Hospital of Ningbo University | Ningbo, Zhejiang | China | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.